NCT01082796View on ClinicalTrials.gov

Cytochrome P450 2C19 Variant is Related to Pharmacokinetics of Glipizide Extended Release Tablet in Chinese Subjects

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

November 30, 2009

Study Completion Date

January 31, 2010

Conditions
GenotypePharmacokinetic
Interventions
DRUG

Glipizide

Each subject received 5 mg glipizide extended release tablet once daily for 7 days.

Trial Locations (1)

730000

Departmant of Clinical Pharmacology, the First Affiliated Hospital of Lanzhou University, Lanzhou

Sponsors
All Listed Sponsors
collaborator

LanZhou University

OTHER

lead

Chinese Academy of Sciences

OTHER_GOV

NCT01082796 - Cytochrome P450 2C19 Variant is Related to Pharmacokinetics of Glipizide Extended Release Tablet in Chinese Subjects | Biotech Hunter | Biotech Hunter